Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
about
Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cellsHuman congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cellsMolecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1)Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells.Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition SystemsBrain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile.Natural killer-cell differentiation by myeloid progenitorsNatural killer receptor repertoires in transplantation.The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.Profiling networks of distinct immune-cells in tumors.Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates.Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cellsHuman natural killer cell development.Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapyHuman NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potentialA novel surface marker (B203.13) of human haemopoietic progenitors, preferentially expressed along the B and myeloid lineages.Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages.No monkey business: why studying NK cells in non-human primates pays off.Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4.Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections.CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells.Decrease in the Frequency of Circulating CD56+CD161+ NK Cells in Human Visceral Leishmaniasis.Early stages in the development of human T, natural killer and thymic dendritic cells.Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis.Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.Can we apply the TH1-TH2 paradigm to all lymphocytes?
P2860
Q24645351-0AABDE6A-ECAB-4C13-8899-049F7C4C3453Q28239745-24069BBA-3A44-413A-A4AF-42B2190DE9A2Q29147544-45310B79-0F1E-4412-BF51-3D0779B77008Q33497623-D16E5498-3EE8-4917-B7AA-5D10A0D0F595Q33696425-C8092DCB-AF44-478A-991C-6A000386A843Q34008344-FE9D58AA-C3DB-49F7-89FE-A60153A95447Q34773999-6E4C2911-9B43-4844-8200-68A27FE81EC1Q35145260-F1D61064-FA16-4097-9DDB-7CED53AF7B0AQ35756252-7B1F86D6-F620-4F8A-A611-5FDA63BAB0D3Q35848872-64DA514A-11E5-449C-B4D5-AA6AA33408E1Q36067826-E6A1A459-853D-4085-8D8B-6CB1D25A59D9Q36380779-54C3124D-9405-45F0-9DCC-8BC16AFA808FQ36401340-D6CCDA7A-AC17-46CC-BA83-7A92929732A9Q36652161-87713936-AF82-495E-BECB-72BDFF2A71C3Q38019320-B87BF978-2976-46DC-896E-A1362BA3F9A4Q38104708-E98854B1-5EB6-4133-8DC7-6507EC6758F0Q39027063-BCA5A7C2-69B0-4A36-BA1C-1A6CB87FE3E5Q41009517-69C22B30-FA69-410E-9DDB-559733770891Q41778611-BA03CB8B-9F6C-4421-89B8-B4FFFDFF1E13Q41833756-CB9C95E6-5E48-4CD3-866A-654C16E89774Q43867808-B22AA20D-36E5-4EF9-8DE9-F3B18D265A29Q45271778-93F236B1-3C86-4195-984E-67A156DC6087Q45609955-A75668FE-36C6-4FAB-9B3B-E853B84E6876Q46726059-33C037EC-5C5F-4FA4-93CB-445028769A6AQ48223922-602233EC-DCE4-495C-8083-C21FC11940CDQ51093053-EB0F2788-8EC4-4B74-ADE7-2BED3BAAA40CQ52127104-DCAA219D-4CD5-42CA-8EC5-1BCEBFD57B3BQ52129115-5B1D913A-A3A7-427E-8499-3405F7918DFDQ52717211-2F104B3B-DFE0-431A-AA98-25596958A1CDQ57265387-71E5B21A-304A-4249-8B0E-8B2C3E0A7A87
P2860
Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Definition of a natural killer ...... he presence of interleukin 12.
@ast
Definition of a natural killer ...... he presence of interleukin 12.
@en
type
label
Definition of a natural killer ...... he presence of interleukin 12.
@ast
Definition of a natural killer ...... he presence of interleukin 12.
@en
prefLabel
Definition of a natural killer ...... he presence of interleukin 12.
@ast
Definition of a natural killer ...... he presence of interleukin 12.
@en
P2093
P2860
P356
P1476
Definition of a natural killer ...... he presence of interleukin 12.
@en
P2093
P2860
P304
P356
10.1084/JEM.184.5.1845
P407
P577
1996-11-01T00:00:00Z